Interpace Biosciences Inc. (NASDAQ: IDXG) is in molecular diagnostics and other platforms and the company entered into an agreement to raise $20 million in a new preferred stock sale. The company also conducted a reverse split that took its shares higher. Before investors even look at the call, this is a mere $31 million stock. Oppenheimer reissued an Outperform rating on January 16 and its target price is now $17.00. That is more than double the current $8.11 share price that had been seen right before Friday’s closing bell.
Meet Group Inc. (NASDAQ: MEET) was named as the Bull of the Day at Zacks on January 14. This is a view that is fundamental and technical and Zacks noted that this stock is seemingly trading at a discount and its small-cap characteristic creates great upside potential. Shares previously closed at $5.30, with a consensus price target of $6.35. Its closing price was $5.77 and its market cap was $413 million at Friday’s close, with a 52-week range of $3.05 to $6.27.
Organigram Holdings Inc. (NASDAQ: OGI) was one of the top stock market gainers back on Wednesday after the cannabis and cannabis-derived products seller posted more than stellar earnings. Many of these cannabis stocks have tried to recover over the past month, but in general the cannabis stock sector remains firmly down from its highs and many legalized marijuana investors have to feel burned over how much money has been lost in this sector from the highs in 2018 and 2019.
After earnings, Raymond James raised Organigram to Outperform from Market Perform in the firm’s Canadian-listed shares with a C$9 target price. The Toronto shares were trading at C$4.26 as of Friday’s closing price, implying that its shares could more than double and that would still be under its C$11.30 share price. Organigram’s U.S.-listed shares closed at $3.26 on Friday, compared with a 52-week high of $8.44.
RTI Surgical Holdings Inc. (NASDAQ: RTIX) was rated as Overweight at Cantor Fitzgerald, but the firm raised its target price to $6 from $4 on January 17. This stock had traded over $4.50 in previous days, but that is after the shares surged from about $2.75 to the higher prices after RTI Surgical reached an agreement to sell its OEM business to Montagu Private Equity for a sum of $490 million.
The transaction is called to close in the first half of 2019 and will leave RTI Surgical as a pure-play spine company that is set to grow that business. With shares at $4.44 late on Friday, its market cap was just $327 million.
Synlogic Inc. (NASDAQ: SYBX) was reiterated as Outperform with a $14 target price (versus a $3.19 prior close) at Wedbush. The firm’s call is a sum of the parts valuation, and it is evaluating potential drug sales out to 2027. This stock is down from a 52-week high of $11.43, and note that it has only an $89 million market cap.
Zynga Inc. (NASDAQ: ZNGA) was started with an Overweight rating and an $8.50 target price (versus a $6.77 prior close) at KeyBanc Capital Markets. Zynga previously had a consensus target price of $7.50, and its 52-week trading range is $4.21 to $6.81.
The analyst still sees mobile games as the fastest-growing segment within gaming and Zynga is said to be well positioned to keep building its game portfolio with expanding margins and additional M&A potential.
For those investors who wonder if stocks can keep surging in 2020, here is the path that can take the Dow to 32,000 in 2020.
We have also included six-month stock performance charts below from StockCharts.com.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.